We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Crism Therapeutics Corp | AQSE:AMC.GB | Aquis Stock Exchange | Ordinary Share | VGG042401262 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.00 | 8.00 | 14.00 | 11.00 | 11.00 | 11.00 | 0.00 | 06:59:38 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAMC
RNS Number : 6060I
Amur Minerals Corporation
05 December 2022
5 December 2022
AMUR MINERALS CORPORATION
(AIM: AMC)
Annual General Meeting Results
The Annual General Meeting ("AGM") of Amur Minerals Corporation ("Amur" or the "Company"), a nickel-copper sulphide mineral exploration development company presently focused on the far east of Russia, was held at 10 a.m. on 5 December 2022 at the office of Fieldfisher LLP, Riverbank House, 2 Swan Lane, London EC4R 3TT, UK. All resolutions were duly passed as follows:
-- Resolution 1; the approval of the Financial Statements and the Report by BDO LLP for the year ended 31 December 2021;
-- Resolution 2; the re-appointment of the Company's auditor BDO LLP; -- Resolution 3; Mr. Robin Young's re-appointment as a Director of the Company; and
-- Resolution 4; authorisation to allot up to 200,000,000 shares during the period between now and the next AGM.
-- Resolution 5; the removal of pre-emptive rights in respect of the authorization to allot up to 200,000,000 shares.
The total number of votes received on the resolutions are as follows:
Resolution Votes % In Votes % Against Votes % of Votes For & Favour Against Total Available Withheld Discretionary Voting Rights* ----------- --------------- -------- ---------- ---------- 1 24,892,720 100.0 0 0.0 24,892,720 1.8% 167,398 2 24,892,720 100.0 0 0.0 24,892,720 1.8% 167,398 3 19,138,575 77.0 5,712,316 23.0 24,850,891 1.8% 209,227 4 20,511,593 82.5 4,339,298 17.5 24,850,891 1.8% 209,227 5 20,511,593 82.5 4,339,298 17.5 24,850,891 1.8% 209,227 --------------- -------- ---------- ---------- ----------- ----------- ----------
* Available Voting Rights equals 1,392,872,315.
Enquiries:
Company Nomad and Broker Public Relations Amur Minerals Corp. S.P. Angel Corporate BlytheRay Finance LLP Robin Young CEO Richard Morrison Megan Ray Adam Cowl Tim Blythe +1 (925) 408-4621 +44 (0) 20 3470 0470 +44 (0) 20 7138 3203
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGEAEASEDNAFFA
(END) Dow Jones Newswires
December 05, 2022 05:43 ET (10:43 GMT)
1 Year Crism Therapeutics Chart |
1 Month Crism Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions